8-K
filed June 20, 2023, 7:59 PM ET
ticker PRPH
CIK 0000868278
other material
confidence high
sentiment neutral
materiality 0.30
ProPhase Labs stockholders approve equity plan amendments, increase share reserves
ProPhase Labs, Inc.
- Amended 2022 Equity Compensation Plan approved, increasing share reserve by 700,000 shares.
- Amended 2022 Directors' Equity Compensation Plan approved, increasing share reserve by 150,000 shares.
- All four director nominees elected: Ted Karkus, Jason Barr, Louis Gleckel, MD, Warren Hirsch.
- Ratification of Morison Cogen LLP as independent auditor for fiscal year 2023 approved (15,066,019 for).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ProPhase Labs, Inc. shareholders approved Ratification of the Appointment of Independent Auditors at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
The ratification of the appointment by the Audit Committee of the board of directors of Morison Cogen LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was approved by the following vote: For Against Abstain Broker Non- Votes 15,066,019 15,111 7,885 3,035,580
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ProPhase Labs, Inc. shareholders approved Approval of the Amended and Restated 2022 Equity Compensation Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The Amended 2022 Plan was approved by the following vote: For Against Abstain Broker Non- Votes 11,415,903 619,094 14,438 3,035,580
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ProPhase Labs, Inc. shareholders approved Approval of the Amended and Restated 2022 Directors’ Equity Compensation Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The Amended 2022 Directors’ Plan was approved by the following vote: For Against Abstain Broker Non- Votes 11,040,479 991,383 21,573 3,035,580
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ProPhase Labs, Inc. shareholders approved Election of Directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Each of the nominees for election to the board of directors was elected to hold office for a one-year term and until their respective successors are elected and qualified by the following votes: Name For Withheld Broker Non- Votes Ted Karkus 12,023,672 29,763 3,035,580 Jason Barr 10,721,866 1,331,569 3,035,580 Louis Gleckel, MD 10,602,209 1,451,226 3,035,580 Warren Hirsch 11,152,966 900,469 3,035,580
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.